Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 4
1996 1
1997 4
1998 6
1999 1
2000 4
2001 8
2002 3
2003 5
2004 1
2005 5
2006 7
2007 2
2008 5
2009 3
2010 5
2011 6
2012 7
2013 6
2014 8
2015 10
2016 7
2017 9
2018 7
2019 5
2020 6
2021 2
2022 1
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D; ACR/EULAR APS Classification Criteria Collaborators. Barbhaiya M, et al. Arthritis Rheumatol. 2023 Oct;75(10):1687-1702. doi: 10.1002/art.42624. Epub 2023 Aug 28. Arthritis Rheumatol. 2023. PMID: 37635643
EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM. Tektonidou MG, et al. Among authors: cuadrado mj. Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15. Ann Rheum Dis. 2019. PMID: 31092409 Free PMC article.
2023 ACR/EULAR antiphospholipid syndrome classification criteria.
Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesús G, Delluc A, Desai S, Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-García A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D; ACR/EULAR APS Classification Criteria Collaborators. Barbhaiya M, et al. Ann Rheum Dis. 2023 Oct;82(10):1258-1270. doi: 10.1136/ard-2023-224609. Epub 2023 Aug 28. Ann Rheum Dis. 2023. PMID: 37640450
Steroids in Lupus: Enemies or Allies.
Enríquez-Merayo E, Cuadrado MJ. Enríquez-Merayo E, et al. Among authors: cuadrado mj. J Clin Med. 2023 May 24;12(11):3639. doi: 10.3390/jcm12113639. J Clin Med. 2023. PMID: 37297834 Free PMC article. Review.
Thematic issue: Biologics in autoimmune diseases.
Sciascia S, Cuadrado MJ. Sciascia S, et al. Among authors: cuadrado mj. Int Immunopharmacol. 2015 Aug;27(2):179. doi: 10.1016/j.intimp.2015.05.006. Epub 2015 May 8. Int Immunopharmacol. 2015. PMID: 25962817 Free article. No abstract available.
Biologics-induced autoimmune diseases.
Perez-Alvarez R, Pérez-de-Lis M, Ramos-Casals M; BIOGEAS study group. Perez-Alvarez R, et al. Curr Opin Rheumatol. 2013 Jan;25(1):56-64. doi: 10.1097/BOR.0b013e32835b1366. Curr Opin Rheumatol. 2013. PMID: 23114587 Review.
Immunotherapy in antiphospholipid syndrome.
Lopez-Pedrera Ch, Aguirre MA, Ruiz-Limon P, Pérez-Sánchez C, Jimenez-Gomez Y, Barbarroja N, Cuadrado MJ. Lopez-Pedrera Ch, et al. Among authors: cuadrado mj. Int Immunopharmacol. 2015 Aug;27(2):200-8. doi: 10.1016/j.intimp.2015.06.006. Epub 2015 Jun 15. Int Immunopharmacol. 2015. PMID: 26086363 Review.
Catastrophic antiphospholipid syndrome (CAPS).
Sciascia S, Lopez-Pedrera C, Roccatello D, Cuadrado MJ. Sciascia S, et al. Among authors: cuadrado mj. Best Pract Res Clin Rheumatol. 2012 Aug;26(4):535-41. doi: 10.1016/j.berh.2012.07.005. Best Pract Res Clin Rheumatol. 2012. PMID: 23040365 Free article. Review.
Renal involvement in antiphospholipid syndrome.
Sciascia S, Cuadrado MJ, Khamashta M, Roccatello D. Sciascia S, et al. Among authors: cuadrado mj. Nat Rev Nephrol. 2014 May;10(5):279-89. doi: 10.1038/nrneph.2014.38. Epub 2014 Mar 18. Nat Rev Nephrol. 2014. PMID: 24642799 Free article. Review.
132 results